Trump Administration Officially Going After the Abortion Pill
If Trump’s re-election didn't motivate you to stockpile abortion pills, here’s your chance.
Photo: Getty Images AbortionPolitics
On Sunday, it will have been 25 years since mifepristone hit the market, a groundbreaking decision that came about because, like most drugs you’d want approved by government standards, the abortion pill was deemed safe and effective. Now, thanks to a gaggle of our nation’s top health chiefs, a team of anti-abortion imbeciles, and a junk study looking to unravel the last half-century of progress, the abortion pill could soon be banned.
On Friday, FDA Commissioner Dr. Marty Makary and Secretary of HHS Robert F. Kennedy Jr. wrote a letter confirming they will re-review the medication in response to a letter from 22 Republican AGs who quietly asked the FDA to re-review the pill in July. The FDA’s decision comes after a months-long push from Senator Josh Hawley (R-Missouri), who’s been busy amplifying a bogus study from the Ethics and Public Policy Center (EPPC), a far-right “think tank.” In April, Hawley wrote to Makary, asking him to review the medication; that same month, he introduced a bill to restrict access to the pill (which has not progressed), and in May, he used its “findings” to also ask RFK Jr. for a review during a congressional hearing. Kennedy told him that he’d already asked Makary for a “complete review.”
The study is also referenced in Makary and Kennedy’s letter, who’ve ignored that it’s essentially a cock-and-bull paper with no peer review, distorted metrics, and published by a nonprofit that has falsely, and baselessly, tied mifepristone to “serious adverse effects.”
“The concerns you have raised in your letter merit close examination,” the FDA letter reads. “This Administration will ensure that women’s health is properly protected by thoroughly investigating the circumstances under which mifepristone can be safely dispensed.” In 2016, the FDA approved the pill to be used up to 10 weeks of pregnancy, up from seven, and in 2023, the agency approved the pill to be prescribed through telehealth, exponentially expanding access. But Republicans want these measures rolled back, claiming it’s for women’s safety.